TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
482
|
398
|
368 |
Financial expenses |
1,236
|
7,802
|
4 |
Earnings before taxes |
-568
|
-7,375
|
3,479 |
EBITDA |
384
|
315
|
280 |
Total assets |
13,550
|
14,619
|
23,749 |
Current assets |
13,408
|
14,422
|
23,497 |
Current liabilities |
943
|
1,309
|
1,739 |
Equity capital |
12,607
|
13,310
|
21,117 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.0%
|
91.0%
|
88.9% |
Turnover per employee |
482
|
398
|
368 |
Profit as a percentage of turnover |
-117.8%
|
-1853.0%
|
945.4% |
Return on assets (ROA) |
4.9%
|
2.9%
|
14.7% |
Current ratio |
1421.8%
|
1101.8%
|
1351.2% |
Return on equity (ROE) |
-4.5%
|
-55.4%
|
16.5% |
Change turnover |
84
|
30
|
6 |
Change turnover % |
21%
|
8%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.